User:Chase Haven/Sandbox 1
From Proteopedia
| Line 34: | Line 34: | ||
=====D-D Interface===== | =====D-D Interface===== | ||
| - | One group analyzed their crystal structure of a fibrin D-Dimer that had been crosslinked by factor XIII. The junction between these two globular regions was not found to be tight; there were no salt bridges and minimal hydrogen bonding. In fact, there appeared to be a layer of solvent between them. This makes sense for the formation of a dynamic fibrin network; as too strong of an end to end interaction would make the clot too rigid. Also interesting about this particular crystal structure was the location of the gamma-gamma cross-link between the D regions: they weren’t visible. Density could not attribute these to a single location, meaning that the covalent bond between E396 and Q398 was highly mobile. This mobility was also observed by another group, who noted that there were several possible orientations in D-Dimer crystals. Taken altogether this provides evidence for the existence of weak interactions at the D-D interface that can slide around and “play,” potentially lending flexibility to the overall network. | + | One group analyzed their crystal structure of a fibrin D-Dimer that had been crosslinked by factor XIII. The junction between these two globular regions was not found to be tight; there were no salt bridges and minimal hydrogen bonding. In fact, there appeared to be a layer of solvent between them. This makes sense for the formation of a dynamic fibrin network; as too strong of an end to end interaction would make the clot too rigid. Also interesting about this particular crystal structure was the location of the gamma-gamma cross-link between the D regions: they weren’t visible. Density could not attribute these to a single location, meaning that the covalent bond between E396 and Q398 was highly mobile. This mobility was also observed by another group, who noted that there were several possible orientations in D-Dimer crystals. Taken altogether this provides evidence for the existence of weak interactions at the D-D interface that can slide around and “play,” potentially lending flexibility to the overall network.<ref>PMID:19296670</ref><ref>PMID:20888119</ref> |
=====A:a Interaction===== | =====A:a Interaction===== | ||
| Line 49: | Line 49: | ||
<scene name='49/493720/Iia_dots_fpa_stick/1'>The interaction of fibrinogen with thrombin</scene> | <scene name='49/493720/Iia_dots_fpa_stick/1'>The interaction of fibrinogen with thrombin</scene> | ||
| - | Proteolytic cleavage of fibrinopeptide A, the N-terminal sixteen amino acid residues of fibrinogen alpha chains, initiates fibrin assembly and the formation of a clot. This reaction is performed by thrombin, s trypsin-like serine protease. Unlike trypsin however, thrombin shows a remarkable specificity for fibrinogen; a highly unique quality that is in contrast with the very broad substrate specificity of other canonical serine proteases. Of the 376 arginine or lysines located in fibrinogen, thrombin only cleaves four (corresponding with the two each of fibrinopeptide A and B). (STUBBS #6) A crystal structure depicting a ternary complex of thrombin with synthetic analogs of fibrinopeptide A and hirudin’s C-terminal domain was produced in attempt to elucidate the interactions necessary for the enzyme’s specificity. | + | Proteolytic cleavage of fibrinopeptide A, the N-terminal sixteen amino acid residues of fibrinogen alpha chains, initiates fibrin assembly and the formation of a clot. This reaction is performed by thrombin, s trypsin-like serine protease. Unlike trypsin however, thrombin shows a remarkable specificity for fibrinogen; a highly unique quality that is in contrast with the very broad substrate specificity of other canonical serine proteases. Of the 376 arginine or lysines located in fibrinogen, thrombin only cleaves four (corresponding with the two each of fibrinopeptide A and B). (STUBBS #6) A crystal structure depicting a ternary complex of thrombin with synthetic analogs of fibrinopeptide A and hirudin’s C-terminal domain was produced in attempt to elucidate the interactions necessary for the enzyme’s specificity.<ref>PMID:1587268</ref> |
| - | The fibrinopeptide A analog showed little secondary structure, although the sections that did demonstrate some important features about the interaction of thrombin with fibrinogen. A short helical sequence of residues 7-10 show a hydrogen bond between the carboxylate oxygen of Asp7 to the amide nitrogen of Ala10. This alternative hydrogen bonding pattern is not characteristic of alpha helices, and is thought to help give rise to the chain reversal occurring after Ala10, which is further stabilized by main-chain hydrogen bonds in the brief helical region, the subsequent amino acids 11 and 12. | + | The fibrinopeptide A analog showed little secondary structure, although the sections that did demonstrate some important features about the interaction of thrombin with fibrinogen. A short helical sequence of residues 7-10 show a hydrogen bond between the carboxylate oxygen of Asp7 to the amide nitrogen of Ala10. This alternative hydrogen bonding pattern is not characteristic of alpha helices, and is thought to help give rise to the chain reversal occurring after Ala10, which is further stabilized by main-chain hydrogen bonds in the brief helical region, the subsequent amino acids 11 and 12.<ref>PMID:1587268</ref> |
| - | This folding pattern facilitates the the formation of a <scene name='49/493720/Basic_hydrophobic_patch1/2'>hydrophobic patch</scene> consisting of the side chains of Phe8, Leu9 and Val15. Analysis of this regions shows a considerable number of contacts occur as this hydrophobic face inserts into the apolar binding site on thrombin. There are however, 3 hydrogen bonds that form a canonical beta-ladder, which are believed to orient substrates into the binding site of the protease. In this case, the antiparallel beta ladder occurs between Gly14 of FPA and Gly216 of thrombin. Other polar contacts include a number of ionic interactions between <scene name='49/493720/Glu11_arg173_intrxn/1'>Arg173 of thrombin and Glu11.</scene> These are believed to also facilitate proper substrate orientation into the active site. | + | This folding pattern facilitates the the formation of a <scene name='49/493720/Basic_hydrophobic_patch1/2'>hydrophobic patch</scene> consisting of the side chains of Phe8, Leu9 and Val15. Analysis of this regions shows a considerable number of contacts occur as this hydrophobic face inserts into the apolar binding site on thrombin. There are however, 3 hydrogen bonds that form a canonical beta-ladder, which are believed to orient substrates into the binding site of the protease. In this case, the antiparallel beta ladder occurs between Gly14 of FPA and Gly216 of thrombin. Other polar contacts include a number of ionic interactions between <scene name='49/493720/Glu11_arg173_intrxn/1'>Arg173 of thrombin and Glu11.</scene> These are believed to also facilitate proper substrate orientation into the active site.<ref>PMID:1587268</ref> |
| - | Sequence comparisons of fibrinopeptide A with different species show conservation of the basic features of their interactions with thrombin. Residues 8 and 9, which form part of the hydrophobic patch, are well conserved and only found to be replaced with other hydrophobic residues. Residue ten (site of chain reversal) makes no contacts with the enzyme and therefore can accomadate several alternative amino acids. The highly conserved glycine at position 12 illustrates the importance of it’s rotational flexibility. In order for the peptide to fold back into the active site following this residue, the peptide has to adopt dihedral angles that no other amino acids are capable of. | + | Sequence comparisons of fibrinopeptide A with different species show conservation of the basic features of their interactions with thrombin. Residues 8 and 9, which form part of the hydrophobic patch, are well conserved and only found to be replaced with other hydrophobic residues. Residue ten (site of chain reversal) makes no contacts with the enzyme and therefore can accomadate several alternative amino acids. The highly conserved glycine at position 12 illustrates the importance of it’s rotational flexibility. In order for the peptide to fold back into the active site following this residue, the peptide has to adopt dihedral angles that no other amino acids are capable of.<ref>PMID:2521950</ref> |
| - | Looking at the binding of the C-terminal <scene name='49/493720/Basic_hirudin_binding/1'>hirudin</scene> analog, we see an extended chain with a short 3-10 helix. It’s interaction with thrombin shows numerous ionic contacts with residues 54-65 of hirudin to the anion-binding site of the protease, which is flanked by two hydrophobic faces. Despite the large number of ionic amino acids in this region there are relatively few hydrogen or ionic bonds; rather binding may be mediated more by their complementary structure. | + | Looking at the binding of the C-terminal <scene name='49/493720/Basic_hirudin_binding/1'>hirudin</scene> analog, we see an extended chain with a short 3-10 helix. It’s interaction with thrombin shows numerous ionic contacts with residues 54-65 of hirudin to the anion-binding site of the protease, which is flanked by two hydrophobic faces. Despite the large number of ionic amino acids in this region there are relatively few hydrogen or ionic bonds; rather binding may be mediated more by their complementary structure. The sequence of the fibrinogen alpha chain from residues 35-43 is believed to contain these necessary features, as kinetic studies show that this region is important for optimum enzymatic efficiency. Therefore, it is hypothesized that there are numerous interactions of fibrinogen with thrombin over a rather large area of both molecules, enabling for the incredible specificity of the protease to its substrate.<ref>PMID:1587268</ref> |
</StructureSection> | </StructureSection> | ||
Revision as of 19:05, 26 April 2014
Fibrinogen
Biological Role
The process of haemostasis is crucial to stemming blood loss following vascular injury. It involves a complex balance of pro- and anti-coagulant activities by a multitude of enzymes and cofactors that ultimately lead to a fibrin clot followed by attenuation of the coagulation response to restore normal blood flow. In short, the serine protease thrombin can be thought of as the star player: thrombin cleaves fibrinogen to fibrin (forming the clot) and also activates a trans-glutaminase (Factor XIII) which will create cross-links in the clot to enhance it's tensile strength. Furthermore, upon the formation of the clot thrombin also activates protein C as part of a negative feedback loop, which in turn degrades various cofactors and ultimately shuts down the coagulation response.[1]
Fibrinogen, the chief proteinaceous component of a clot, is a 340 kDa multidomain glycoprotein consisting of termed , and . It circulates in blood at concentrations generally ranging from 2 to 3 mg/mL.[2] Vascular injury exposes tissue factor-bearing subendothelial cells to flowing blood, triggering a coagulation response in order to generate thrombin. This serine protease has a unique specificity for cleavage sites on fibrinogen alpha and beta chains, and when cleaved fibrinopeptides A and B are released. This results in the exposure of polymerization sites known as "knobs", which are complementary to "holes" on other fibrinogen molecules. This interaction is non-covalent but strong enough to support the spontaneous growth of fibrin fibers and ultimately a fibrin clot network capable of stemming blood loss in vivo.[3]
Fibrin clots are highly heterogeneous; numerous factors play a role in determining fiber diameter, types of branch points, and number of branching fibers per unit area. Some of these factors are well understood, such as the effects of higher thrombin or fibrinogen concentrations. Others are less understood, such as calcium and metal ion levels, circulating lipid content, coagulation or fibrinolytic protein levels, some studies have even shown smoking and diabetes may change the structural layout or integrity of fibrin clots.[4]
| |||||||||||
References
- ↑ Mann KG, Brummel-Ziedins K, Orfeo T, Butenas S. Models of blood coagulation. Blood Cells Mol Dis. 2006 Mar-Apr;36(2):108-17. Epub 2006 Feb 23. PMID:16500122 doi:http://dx.doi.org/10.1016/j.bcmd.2005.12.034
- ↑ Kollman JM, Pandi L, Sawaya MR, Riley M, Doolittle RF. Crystal structure of human fibrinogen. Biochemistry. 2009 May 12;48(18):3877-86. PMID:19296670 doi:10.1021/bi802205g
- ↑ Falvo MR, Gorkun OV, Lord ST. The molecular origins of the mechanical properties of fibrin. Biophys Chem. 2010 Nov;152(1-3):15-20. doi: 10.1016/j.bpc.2010.08.009. PMID:20888119 doi:http://dx.doi.org/10.1016/j.bpc.2010.08.009
- ↑ Wolberg AS. Determinants of fibrin formation, structure, and function. Curr Opin Hematol. 2012 Sep;19(5):349-56. doi: 10.1097/MOH.0b013e32835673c2. PMID:22759629 doi:http://dx.doi.org/10.1097/MOH.0b013e32835673c2
- ↑ Kollman JM, Pandi L, Sawaya MR, Riley M, Doolittle RF. Crystal structure of human fibrinogen. Biochemistry. 2009 May 12;48(18):3877-86. PMID:19296670 doi:10.1021/bi802205g
- ↑ Kollman JM, Pandi L, Sawaya MR, Riley M, Doolittle RF. Crystal structure of human fibrinogen. Biochemistry. 2009 May 12;48(18):3877-86. PMID:19296670 doi:10.1021/bi802205g
- ↑ Kollman JM, Pandi L, Sawaya MR, Riley M, Doolittle RF. Crystal structure of human fibrinogen. Biochemistry. 2009 May 12;48(18):3877-86. PMID:19296670 doi:10.1021/bi802205g
- ↑ Cheng Y, LeGall T, Oldfield CJ, Dunker AK, Uversky VN. Abundance of intrinsic disorder in protein associated with cardiovascular disease. Biochemistry. 2006 Sep 5;45(35):10448-60. PMID:16939197 doi:http://dx.doi.org/10.1021/bi060981d
- ↑ Kollman JM, Pandi L, Sawaya MR, Riley M, Doolittle RF. Crystal structure of human fibrinogen. Biochemistry. 2009 May 12;48(18):3877-86. PMID:19296670 doi:10.1021/bi802205g
- ↑ Gallivan JP, Dougherty DA. Cation-pi interactions in structural biology. Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9459-64. PMID:10449714
- ↑ Zhang JZ, Redman CM. Role of interchain disulfide bonds on the assembly and secretion of human fibrinogen. J Biol Chem. 1994 Jan 7;269(1):652-8. PMID:8276866
- ↑ Kollman JM, Pandi L, Sawaya MR, Riley M, Doolittle RF. Crystal structure of human fibrinogen. Biochemistry. 2009 May 12;48(18):3877-86. PMID:19296670 doi:10.1021/bi802205g
- ↑ Zhang JZ, Redman CM. Role of interchain disulfide bonds on the assembly and secretion of human fibrinogen. J Biol Chem. 1994 Jan 7;269(1):652-8. PMID:8276866
- ↑ Falvo MR, Gorkun OV, Lord ST. The molecular origins of the mechanical properties of fibrin. Biophys Chem. 2010 Nov;152(1-3):15-20. doi: 10.1016/j.bpc.2010.08.009. PMID:20888119 doi:http://dx.doi.org/10.1016/j.bpc.2010.08.009
- ↑ Kollman JM, Pandi L, Sawaya MR, Riley M, Doolittle RF. Crystal structure of human fibrinogen. Biochemistry. 2009 May 12;48(18):3877-86. PMID:19296670 doi:10.1021/bi802205g
- ↑ Falvo MR, Gorkun OV, Lord ST. The molecular origins of the mechanical properties of fibrin. Biophys Chem. 2010 Nov;152(1-3):15-20. doi: 10.1016/j.bpc.2010.08.009. PMID:20888119 doi:http://dx.doi.org/10.1016/j.bpc.2010.08.009
- ↑ Falvo MR, Gorkun OV, Lord ST. The molecular origins of the mechanical properties of fibrin. Biophys Chem. 2010 Nov;152(1-3):15-20. doi: 10.1016/j.bpc.2010.08.009. PMID:20888119 doi:http://dx.doi.org/10.1016/j.bpc.2010.08.009
- ↑ Falvo MR, Gorkun OV, Lord ST. The molecular origins of the mechanical properties of fibrin. Biophys Chem. 2010 Nov;152(1-3):15-20. doi: 10.1016/j.bpc.2010.08.009. PMID:20888119 doi:http://dx.doi.org/10.1016/j.bpc.2010.08.009
- ↑ Collet JP, Moen JL, Veklich YI, Gorkun OV, Lord ST, Montalescot G, Weisel JW. The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis. Blood. 2005 Dec 1;106(12):3824-30. Epub 2005 Aug 9. PMID:16091450 doi:http://dx.doi.org/10.1182/blood-2005-05-2150
- ↑ Murakawa M, Okamura T, Kamura T, Shibuya T, Harada M, Niho Y. Diversity of primary structures of the carboxy-terminal regions of mammalian fibrinogen A alpha-chains. Characterization of the partial nucleotide and deduced amino acid sequences in five mammalian species; rhesus monkey, pig, dog, mouse and Syrian hamster. Thromb Haemost. 1993 Apr 1;69(4):351-60. PMID:8497848
- ↑ Doolittle RF, Kollman JM. Natively unfolded regions of the vertebrate fibrinogen molecule. Proteins. 2006 May 1;63(2):391-7. PMID:16288455 doi:http://dx.doi.org/10.1002/prot.20758
- ↑ Wang YZ, Patterson J, Gray JE, Yu C, Cottrell BA, Shimizu A, Graham D, Riley M, Doolittle RF. Complete sequence of the lamprey fibrinogen alpha chain. Biochemistry. 1989 Dec 12;28(25):9801-6. PMID:2611265
- ↑ Tatham AS, Shewry PR. Comparative structures and properties of elastic proteins. Philos Trans R Soc Lond B Biol Sci. 2002 Feb 28;357(1418):229-34. PMID:11911780 doi:http://dx.doi.org/10.1098/rstb.2001.1031
- ↑ Falvo MR, Millard D, O'Brien ET 3rd, Superfine R, Lord ST. Length of tandem repeats in fibrin's alphaC region correlates with fiber extensibility. J Thromb Haemost. 2008 Nov;6(11):1991-3. doi: 10.1111/j.1538-7836.2008.03147.x., Epub 2008 Aug 28. PMID:18761721 doi:http://dx.doi.org/10.1111/j.1538-7836.2008.03147.x
- ↑ Murakawa M, Okamura T, Kamura T, Shibuya T, Harada M, Niho Y. Diversity of primary structures of the carboxy-terminal regions of mammalian fibrinogen A alpha-chains. Characterization of the partial nucleotide and deduced amino acid sequences in five mammalian species; rhesus monkey, pig, dog, mouse and Syrian hamster. Thromb Haemost. 1993 Apr 1;69(4):351-60. PMID:8497848
- ↑ Stubbs MT, Oschkinat H, Mayr I, Huber R, Angliker H, Stone SR, Bode W. The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur J Biochem. 1992 May 15;206(1):187-95. PMID:1587268
- ↑ Stubbs MT, Oschkinat H, Mayr I, Huber R, Angliker H, Stone SR, Bode W. The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur J Biochem. 1992 May 15;206(1):187-95. PMID:1587268
- ↑ Stubbs MT, Oschkinat H, Mayr I, Huber R, Angliker H, Stone SR, Bode W. The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur J Biochem. 1992 May 15;206(1):187-95. PMID:1587268
- ↑ Mosesson MW, Siebenlist KR, Amrani DL, DiOrio JP. Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1113-7. PMID:2521950
- ↑ Stubbs MT, Oschkinat H, Mayr I, Huber R, Angliker H, Stone SR, Bode W. The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur J Biochem. 1992 May 15;206(1):187-95. PMID:1587268
